FI873467A - Menetelmä 5-amino-4-hydroksivaleriaanahappojohdannaisten valmistamiseksi - Google Patents
Menetelmä 5-amino-4-hydroksivaleriaanahappojohdannaisten valmistamiseksi Download PDFInfo
- Publication number
- FI873467A FI873467A FI873467A FI873467A FI873467A FI 873467 A FI873467 A FI 873467A FI 873467 A FI873467 A FI 873467A FI 873467 A FI873467 A FI 873467A FI 873467 A FI873467 A FI 873467A
- Authority
- FI
- Finland
- Prior art keywords
- amino
- cycloalkyl
- aryl
- lower alkyl
- preparation
- Prior art date
Links
- TYMZJFJDBQLYHB-UHFFFAOYSA-N 5-amino-4-hydroxypentanoic acid Chemical class NCC(O)CCC(O)=O TYMZJFJDBQLYHB-UHFFFAOYSA-N 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 4
- 125000003118 aryl group Chemical group 0.000 abstract 4
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 4
- -1 amino, hydroxyl Chemical group 0.000 abstract 3
- 150000001413 amino acids Chemical class 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 150000002431 hydrogen Chemical class 0.000 abstract 2
- 125000000547 substituted alkyl group Chemical group 0.000 abstract 2
- RAHZWNYVWXNFOC-UHFFFAOYSA-N Sulphur dioxide Chemical group O=S=O RAHZWNYVWXNFOC-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 125000003277 amino group Chemical group 0.000 abstract 1
- 230000003276 anti-hypertensive effect Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 150000002596 lactones Chemical class 0.000 abstract 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 abstract 1
- 239000012038 nucleophile Substances 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 230000008707 rearrangement Effects 0.000 abstract 1
- 239000002461 renin inhibitor Substances 0.000 abstract 1
- 229940086526 renin-inhibitors Drugs 0.000 abstract 1
- 238000007142 ring opening reaction Methods 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C227/04—Formation of amino groups in compounds containing carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C247/00—Compounds containing azido groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/02—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
- C07C57/03—Monocarboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/26—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing rings other than six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/32—Oxygen atoms
- C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/86—Renin inhibitors
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Furan Compounds (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH324886 | 1986-08-13 | ||
CH324886 | 1986-08-13 |
Publications (4)
Publication Number | Publication Date |
---|---|
FI873467A0 FI873467A0 (fi) | 1987-08-10 |
FI873467A true FI873467A (fi) | 1988-02-14 |
FI90762B FI90762B (fi) | 1993-12-15 |
FI90762C FI90762C (fi) | 1994-03-25 |
Family
ID=4251859
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI873467A FI90762C (fi) | 1986-08-13 | 1987-08-10 | Menetelmä 5-amino-4-hydroksivaleriaanahappojohdannaisten valmistamiseksi |
Country Status (14)
Country | Link |
---|---|
US (2) | US4898977A (fi) |
EP (1) | EP0258183B1 (fi) |
JP (1) | JP2571230B2 (fi) |
KR (1) | KR950013635B1 (fi) |
AT (1) | ATE86971T1 (fi) |
DD (1) | DD269148A5 (fi) |
DE (1) | DE3784812D1 (fi) |
DK (1) | DK420887A (fi) |
ES (1) | ES2053582T3 (fi) |
FI (1) | FI90762C (fi) |
HU (3) | HU198445B (fi) |
IL (1) | IL83497A (fi) |
MX (1) | MX7727A (fi) |
PT (1) | PT85520B (fi) |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4992562A (en) * | 1985-08-09 | 1991-02-12 | Pfizer Inc. | Renin inhibitors containing 5-amino-2,5-disubstituted-4-hydroxypentanoic acid residues |
US5076973A (en) * | 1988-10-24 | 1991-12-31 | Arizona Board Of Regents | Synthesis of dolastatin 3 |
AU629867B2 (en) * | 1988-11-17 | 1992-10-15 | Imperial Chemical Industries Plc | Triazolo (4,3a) pyrazine derivatives |
GB8912659D0 (en) * | 1989-06-02 | 1989-07-19 | Ici Plc | Process |
GB8927915D0 (en) * | 1989-12-11 | 1990-02-14 | Hoffmann La Roche | Novel alcohols |
DE4008403A1 (de) * | 1990-03-16 | 1991-09-19 | Merck Patent Gmbh | Glykolsaeurederivate |
US5436339A (en) * | 1991-03-06 | 1995-07-25 | Abbott Laboratories | Process for the preparation of a substituted diaminoalcohol |
EP0546230A1 (en) * | 1991-12-10 | 1993-06-16 | Merrell Dow Pharmaceuticals Inc. | Novel process for preparing 4-amino-5-hexenoic acid |
US5294737A (en) * | 1992-02-27 | 1994-03-15 | The Research Foundation State University Of New York | Process for the production of chiral hydroxy-β-lactams and hydroxyamino acids derived therefrom |
AU688403B2 (en) * | 1993-11-03 | 1998-03-12 | Commonwealth Scientific And Industrial Research Organisation | Allylic chain transfer agents |
US5977278A (en) * | 1993-11-03 | 1999-11-02 | E. I. Du Pont De Nemours And Company | Polymers formed from allylic chain transfer agents |
IL111484A (en) * | 1993-11-03 | 2001-06-14 | Commw Scient Ind Res Org | Polymerization process using pendant chain transfer means to regulate the molecular weight, the polymers thus obtained and a number of new pesticide compounds |
US5475138A (en) * | 1994-07-07 | 1995-12-12 | Pharm-Eco Laboratories Incorporated | Method preparing amino acid-derived diaminopropanols |
US5473104A (en) * | 1994-09-13 | 1995-12-05 | Neurocrine Biosciences, Inc. | Process for the preparation of L-carnitine |
US5760019A (en) * | 1996-07-12 | 1998-06-02 | The Research Foundation Of State University Of New York | Silanol enzyme inhibitors |
US6833460B2 (en) * | 1999-06-18 | 2004-12-21 | E. I. Du Pont De Nemours And Company | Preparation and use of gamma-butyrolactones as cross-linking agents |
US6423850B1 (en) | 1999-06-18 | 2002-07-23 | E.I. Du Pont De Nemours And Company | Preparation and use of gamma-butyrolactones as cross-linking agents |
US8026280B2 (en) * | 2001-03-27 | 2011-09-27 | Errant Gene Therapeutics, Llc | Histone deacetylase inhibitors |
US7842727B2 (en) * | 2001-03-27 | 2010-11-30 | Errant Gene Therapeutics, Llc | Histone deacetylase inhibitors |
US7314953B2 (en) * | 2001-03-27 | 2008-01-01 | Errant Gene Therapeutics, Llc | Treatment of lung cells with histone deacetylase inhibitors |
US7312247B2 (en) * | 2001-03-27 | 2007-12-25 | Errant Gene Therapeutics, Llc | Histone deacetylase inhibitors |
EP1511477A4 (en) * | 2002-05-22 | 2008-04-09 | Errant Gene Therapeutics Llc | HISTONE DEACETYLASE INHIBITORS BASED ON ALPHA-KETO-EPOXYDE COMPOUNDS |
WO2006052916A2 (en) * | 2004-11-08 | 2006-05-18 | Errant Gene Therapeutics, Inc. | Histone deacetylase inhibitors |
CN101160281A (zh) * | 2005-04-06 | 2008-04-09 | 特瓦制药工业有限公司 | 结晶形态的普瑞巴林 |
US7488846B2 (en) * | 2005-04-11 | 2009-02-10 | Teva Pharmaceuical Industries Ltd. | Pregabalin free of lactam and a process for preparation thereof |
WO2006110783A2 (en) * | 2005-04-11 | 2006-10-19 | Teva Pharmaceutical Industries Ltd. | Process for making (s)-pregabalin |
MX2007000525A (es) * | 2005-05-10 | 2007-03-28 | Teva Pharma | Pregabalina libre de acido isobutilglutarico y un proceso para la preparacion de ella. |
EP1879854B1 (en) * | 2005-05-10 | 2011-09-07 | Teva Pharmaceutical Industries Ltd | Optical resolution of 3-carbamoylmethyl-5-methyl hexanoic acid |
ATE486841T1 (de) * | 2005-05-10 | 2010-11-15 | Teva Pharma | Verfahren zur herstellung von pregabalin und salzen daraus |
KR20080034205A (ko) * | 2005-09-19 | 2008-04-18 | 테바 파마슈티컬 인더스트리즈 리미티드 | (s)-프레가발린의 신규한 합성을 위한 주요 중간체인 키랄3-카르바모일메틸-5-메틸 헥산산 |
EP2019817A2 (en) * | 2006-05-24 | 2009-02-04 | Teva Pharmaceutical Industries Ltd. | Processes for the preparation of r-(+)-3-(carbamoyl methyl)-5-methylhexanoic acid and salts thereof |
US20080015385A1 (en) * | 2006-05-31 | 2008-01-17 | Lilach Hedvati | Preparation of (S)-pregabalin-nitrile |
WO2007143113A2 (en) * | 2006-05-31 | 2007-12-13 | Teva Pharmaceutical Industries Ltd. | The use of enzymatic resolution for the preparation of intermediates of pregabalin |
TW200846308A (en) * | 2007-03-22 | 2008-12-01 | Teva Pharma | Synthesis of (s)-(+)-3-(aminomethyl)-5-methyl hexanoic acid |
DE102007049039A1 (de) | 2007-10-11 | 2009-04-16 | Reuter Chemischer Apparatebau Kg | Verfahren zur Herstellung von 8-Hydrazino-8-Aryl-Octanoylderivaten und deren Verwendung |
KR20100107500A (ko) * | 2008-06-23 | 2010-10-05 | 테바 파마슈티컬 인더스트리즈 리미티드 | (s) 또는 (r)-이소-부틸-글루타릭 에스테르의 입체선택적 효소 합성방법 |
US8257462B2 (en) * | 2009-10-15 | 2012-09-04 | Federal-Mogul Corporation | Iron-based sintered powder metal for wear resistant applications |
JP5585172B2 (ja) * | 2010-04-05 | 2014-09-10 | 三菱瓦斯化学株式会社 | 脂環式エステル化合物の製造方法 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB960005A (en) * | 1961-01-18 | 1964-06-10 | Distillers Co Yeast Ltd | Production of acrylic and methacrylic esters |
DE1914380A1 (de) * | 1969-03-21 | 1970-10-01 | Basf Ag | Verfahren zur Herstellung von Buta-1,3-dien-1-carbonsaeurealkylestern |
US4031115A (en) * | 1976-03-29 | 1977-06-21 | Chevron Research Company | 4-Pentenoic acid conversion |
CH634815A5 (fr) * | 1978-08-30 | 1983-02-28 | Firmenich & Cie | Procede pour la preparation d'esters et acides gamma, delta-insatures. |
US4372974A (en) * | 1980-06-25 | 1983-02-08 | New York University | Anticonvulsive compositions and method of treating convulsive disorders |
US4609643A (en) * | 1980-08-06 | 1986-09-02 | Aktiebolaget Hassle | Renin inhibitors, treatments and dipeptide synthesis |
US4487963A (en) * | 1983-01-03 | 1984-12-11 | Merck & Co., Inc. | Enantioselective synthesis of 4-amino-3-hydroxy-2,4-(disubstituted)pentanoic acid |
US4613676A (en) * | 1983-11-23 | 1986-09-23 | Ciba-Geigy Corporation | Substituted 5-amino-4-hydroxyvaleryl derivatives |
EP0486478A3 (en) * | 1984-08-06 | 1992-08-12 | The Upjohn Company | Renin-inhibiting peptides |
US4727060A (en) * | 1984-11-13 | 1988-02-23 | Ciba-Geigy Corporation | Novel 5-amino-4-hydroxyvaleryl derivatives |
US4665055A (en) * | 1985-06-17 | 1987-05-12 | Merck & Co., Inc. | Peptide renin inhibitors |
WO1988003022A1 (en) * | 1986-10-31 | 1988-05-05 | Pfizer Inc. | Relatively low molecular weight polypeptides as renin inhibitors |
-
1987
- 1987-08-07 AT AT87810450T patent/ATE86971T1/de not_active IP Right Cessation
- 1987-08-07 ES ES87810450T patent/ES2053582T3/es not_active Expired - Lifetime
- 1987-08-07 DE DE8787810450T patent/DE3784812D1/de not_active Expired - Fee Related
- 1987-08-07 EP EP87810450A patent/EP0258183B1/de not_active Expired - Lifetime
- 1987-08-10 FI FI873467A patent/FI90762C/fi not_active IP Right Cessation
- 1987-08-11 IL IL83497A patent/IL83497A/xx unknown
- 1987-08-11 DD DD87305909A patent/DD269148A5/de not_active IP Right Cessation
- 1987-08-11 PT PT85520A patent/PT85520B/pt not_active IP Right Cessation
- 1987-08-12 HU HU873654A patent/HU198445B/hu not_active IP Right Cessation
- 1987-08-12 KR KR1019870008819A patent/KR950013635B1/ko not_active IP Right Cessation
- 1987-08-12 HU HU883004A patent/HU202218B/hu not_active IP Right Cessation
- 1987-08-12 JP JP62200085A patent/JP2571230B2/ja not_active Expired - Lifetime
- 1987-08-12 HU HU883005A patent/HU200981B/hu not_active IP Right Cessation
- 1987-08-12 MX MX772787A patent/MX7727A/es unknown
- 1987-08-12 DK DK420887A patent/DK420887A/da not_active Application Discontinuation
- 1987-08-13 US US07/085,437 patent/US4898977A/en not_active Expired - Fee Related
-
1989
- 1989-10-24 US US07/426,927 patent/US5010189A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US4898977A (en) | 1990-02-06 |
FI90762B (fi) | 1993-12-15 |
IL83497A0 (en) | 1988-01-31 |
KR950013635B1 (ko) | 1995-11-13 |
FI90762C (fi) | 1994-03-25 |
KR880002808A (ko) | 1988-05-11 |
DE3784812D1 (de) | 1993-04-22 |
FI873467A0 (fi) | 1987-08-10 |
EP0258183B1 (de) | 1993-03-17 |
DD269148A5 (de) | 1989-06-21 |
DK420887D0 (da) | 1987-08-12 |
HU202218B (en) | 1991-02-28 |
EP0258183A3 (en) | 1989-07-26 |
EP0258183A2 (de) | 1988-03-02 |
DK420887A (da) | 1988-02-14 |
US5010189A (en) | 1991-04-23 |
MX7727A (es) | 1993-12-01 |
ATE86971T1 (de) | 1993-04-15 |
PT85520B (pt) | 1990-06-29 |
HU198445B (en) | 1989-10-30 |
JPS6357561A (ja) | 1988-03-12 |
ES2053582T3 (es) | 1994-08-01 |
PT85520A (en) | 1987-09-01 |
IL83497A (en) | 1993-02-21 |
JP2571230B2 (ja) | 1997-01-16 |
HUT44478A (en) | 1988-03-28 |
HU200981B (en) | 1990-09-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI873467A (fi) | Menetelmä 5-amino-4-hydroksivaleriaanahappojohdannaisten valmistamiseksi | |
DK2285A (da) | Osteogen faktor og middel indeholdende denne faktor | |
GR3008221T3 (fi) | ||
DE3650518D1 (de) | Beta-Lactamantibiotika, Verfahren zur Herstellung und ihre Verwendung als und in Arzneimitteln | |
AT383123B (de) | Verfahren zur herstellung von neuen (+)-catechin- alpha- monohydrat | |
ATE51617T1 (de) | Verfahren zur herstellung von 4-phenyl-pyrrolderivaten. | |
DE3667059D1 (en) | Benzodipyrroles, processes for their preparation and pharmaceutical compositions containing these compounds | |
DK337883A (da) | Fremgangsmaade til fremstilling af muramylpeptider eller salte deraf | |
DK226285D0 (da) | Beta-lactamforbindelser, deres fremstilling og anvendelse som laegemidler eller vaekstfremmende midler til dyr samt mellemprodukter til fremstillingen | |
ATE14126T1 (de) | Verfahren zur herstellung von 2-acyl1,3,4,6,7,11b-2h-hexahydro-4-pyrazino(2,1a)isochinolinonen und zwischenprodukte. | |
ATE48594T1 (de) | Verfahren zur herstellung von acylurethanen und deren verwendung. | |
AU2021988A (en) | Novel compounds and processes for synthesis thereof | |
ATE76408T1 (de) | Carbapenem-antibiotika, ein verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen. | |
ATE101391T1 (de) | Verfahren zur herstellung von in stellung 3 durch eine halogenierte gesaettigte kette substituierten cyclopropancarbonsaeurederivaten. | |
SE8301928L (sv) | Nya karbapenemderivat och forfarande for framstellning derav | |
DK469285D0 (da) | Thiadiazolderivater, der indvirker paa centralnervesystemet, fremgangsmaade til fremstilling deraf og midler indeholdende derivaterne | |
EP0232027A3 (en) | N-carboxyalkyl compounds | |
ES2130392T3 (es) | Procedimiento para la preparacion de acido clavulanico. | |
DE3173404D1 (en) | Biologically active heterobicyclic hydroximidates and thiolhydroximidates and carbamate ester derivatives thereof | |
ATE39688T1 (de) | Verfahren zur herstellung von aminotriazinonderivaten. | |
ATE204582T1 (de) | Von neurokininen abgeleitete pseudopeptide, verfahren für ihre herstellung und sie enthaltende pharmazeutische zubereitungen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
BB | Publication of examined application | ||
PC | Transfer of assignment of patent |
Owner name: NOVARTIS AG |
|
MM | Patent lapsed | ||
MM | Patent lapsed |
Owner name: NOVARTIS AG |